Modeling the interaction of peroxynitrite with low-density lipoproteins. III: The role of antioxidants

被引:6
|
作者
Stanbro, WD
机构
[1] Los Alamos, NM 87544
关键词
D O I
10.1006/jtbi.2000.2081
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Peroxynitrite is a candidate for the substance responsible for the initiation of peroxidation of low-density lipoproteins (LDL) in blood. This is believed to be the initial step in the formation of atherosclerotic plaque. Using kinetic arguments, this paper examines possible routes in both LDL particles and in the surrounding plasma for antioxidants to block peroxidation. The antioxidants considered include ascorbate ion, glutathione and human serum albumin in plasma as well as a-tocopherol, ubiquinone-10 and carotenoids in the LDL particles. The results suggest that in the plasma compartment the most efficacious blocking mechanism is the reaction of ascorbate ion with the peroxynitrite precursor, superoxide ion. The situation in LDL particles is much less clear cut because of the paucity of kinetic data in this medium. However, some constraints are suggested on the requirements for an effective antioxidant. (C) 2000 Academic Press.
引用
收藏
页码:473 / 482
页数:10
相关论文
共 50 条
  • [31] METABOLISM OF VERY LOW-DENSITY LIPOPROTEINS AND LOW-DENSITY LIPOPROTEINS IN NORMAL AND DYSLIPOPROTEINEMIC MAN
    SCHAEFER, EJ
    ZECH, LA
    BREWER, HB
    JOURNAL OF THE AMERICAN OIL CHEMISTS SOCIETY, 1979, 56 (02) : A205 - A205
  • [32] Circulating oxidized low-density lipoproteins and antibody to oxidized low-density lipoproteins in Type 2 diabetic subjects: the role of glycoxidation
    Sartore, G
    Piarulli, F
    Lapolla, A
    Cantaro, S
    Reitano, R
    Fiore, C
    Marin, R
    Bassan, S
    Piconi, L
    Manzato, E
    Fedele, D
    DIABETOLOGIA, 2004, 47 : A412 - A412
  • [33] Interaction of native and modified low-density lipoproteins with extracellular matrix
    Chait, A
    Wight, TN
    CURRENT OPINION IN LIPIDOLOGY, 2000, 11 (05) : 457 - 463
  • [34] INTERACTION OF PROSTAGLANDINS WITH LOW-DENSITY LIPOPROTEINS OF HUMAN-BLOOD
    MARTYNOVA, MA
    MANEVICH, EM
    VODOVOZOVA, EL
    MUZYA, GI
    BEZUGLOV, VV
    MOLOTKOVSKII, YG
    BERGELSON, LD
    BIOCHEMISTRY-MOSCOW, 1988, 53 (05) : 623 - 628
  • [35] NONRECEPTOR INTERACTION OF LOW-DENSITY LIPOPROTEINS WITH HUMAN-FIBROBLASTS
    KLIMOV, AN
    POPOV, AV
    ANDREEVA, LI
    VINOGRADOV, AG
    PLESKOV, VM
    KOBYAKOVA, VA
    BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, 1983, 95 (04) : 455 - 457
  • [36] EFFECT OF THROMBIN MODIFICATION OF LOW-DENSITY LIPOPROTEINS ON THEIR INTERACTION WITH FIBRONECTIN
    CHULKOVA, TM
    VOPROSY MEDITSINSKOI KHIMII, 1986, 32 (06): : 70 - 73
  • [37] OXIDATION OF LOW-DENSITY LIPOPROTEINS BY RAT MESANGIAL CELLS AND THE INTERACTION OF OXIDIZED LOW-DENSITY LIPOPROTEINS WITH RAT MESANGIAL CELLS IN-VITRO
    FERNANDO, RL
    VARGHESE, Z
    MOORHEAD, JF
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1993, 8 (06) : 512 - 518
  • [38] Effect of pravastatin on apolipoproteins B and C-III in very-low-density lipoproteins and low-density lipoproteins
    Sacks, FM
    Alaupovic, P
    Moye, LA
    AMERICAN JOURNAL OF CARDIOLOGY, 2002, 90 (02): : 165 - +
  • [39] LOW-DENSITY LIPOPROTEINS IN ATHEROSCLEROSIS
    RUDEL, LL
    PARKS, JS
    JOHNSON, FL
    BABIAK, J
    JOURNAL OF LIPID RESEARCH, 1986, 27 (05) : 465 - 474
  • [40] LOW-DENSITY LIPOPROTEINS AND HYPERCHOLESTEROLEMIA
    ASSMANN, G
    FUNKE, H
    SCHMITZ, G
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1989, 39-2 (8A): : 996 - 1004